A recombinant vaccinia virus containing cloned DNA sequences coding for the three structural proteins and nonstructural proteins NS, and NS2,, of dengue type 4 virus was constructed. Infection of CV-1 cells with this recombinant virus produced dengue virus structural proteins as well as the nonstructural protein NS,. These proteins were precipitated by specific antisera and exhibited the same molecular size and glycosylation patterns as authentic dengue virus proteins. Infection of cotton rats with the recombinant virus induced NS1 antibodies in 1 of 11 animals. However, an immune response to the PreM and E glycoproteins was not detected. A reduced level of gene expression was probably the reason for the limited serologic response to these dengue virus antigens.
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Infections by dengue virus types 1 through 4 continue to pose a major public health problem in many geographic areas, especially in Southeast Asia, the South Pacific, the Caribbean, and Central and South America. Dengue virus infections also occasionally cause hemorrhagic fever with a shock syndrome which has a high mortality rate in children and young adults (4, 10) . Unfortunately, there is a lack of specific immunoprophylactic measures against dengue virus, and prevention of dengue virus infection still depends on mosquito vector control, which is labor intensive and often ineffective.
Like other members of the flavivirus family, extracellular dengue virus has a relatively simple structure. Virions contain only three virus-coded proteins, designated capsid (C) protein, membrane (M) protein, and envelope (E) glycoprotein (3, 6, 14) . Intracellular virus, which is also infectious, lacks M but contains another glycoprotein, PreM, from which M is derived by cleavage (11) . Both C and M are internal proteins. The surface envelope glycoprotein is the major site responsible for neutralization of infectivity by specific antibodies (12, 13) . The envelope glycoprotein also exhibits hemagglutinating activity and is responsible for adsorption to the cell surface (16) . Several nonstructural proteins have also been identified in dengue virus-infected cells. Among them is nonstructural protein NS,, which is a glycoprotein and was originally described as a soluble complement-fixing antigen. NS, may also play an important role in mediating immunity, since the analogous NS, glycoprotein of yellow fever virus has been shown to be a protective antigen in mice and in primates (7, 8) . Recently, the NS, of dengue type 2 virus was also shown to be a protective antigen (9) .
The dengue type 4 (17) . The PreM protein band was completely sensitive to endoglycosidase H treatment, yielding a band of 17 kDa, a reduction of 3 kDa in molecular size (Fig. 2B) However, all the animals developed a high titer of neutralizing antibodies against vaccinia virus (1:1,000 to 1:5,000), indicating that they had been infected with the recombinant virus.
Radioimmunoprecipitation with 35S-labeled dengue virus proteins was also performed in an attempt to detect low levels of dengue virus-specific antibodies. NS1 glycoprotein was precipitated by the serum of one animal at 6 weeks after immunization (Fig. 3) . However, the same antiserum did not precipitate either the E or PreM glycoprotein. Sera from 10 other animals were all negative by this assay. Thus, the recombinant vaccinia virus failed to elicit a detectable seroresponse to the E or PreM glycoprotein.
There are several factors which may have contributed to the poor immune response to the NS1 protein as well as to our failure to detect a seroresponse to the E glycoprotein. Most 
